Sami-Sabinsa to purchase 150 million units of renewable power over next 25 years to power five of its manufacturing plants
The company signed a long-term mutual agreement with O2 Renewable Energy.
Pictured: A captive solar farm powering the Sami-Sabinsa Group facilities. Photo from Sami-Sabinsa Group.
Sami-Sabinsa Group (Bengaluru, India) announced it will purchase 150 million units (MU) of renewable power over a 25-year period thanks to a new, long-term mutual agreement signed with O2 Renewable Energy, “a subsidiary of the renowned Singapore-based renewable energy developer O2 Energy SG PTE Ltd.,” the company’s press release states.
The captive solar energy will be used to power five Sami-Sabinsa manufacturing plants in Karnataka, India. In addition, the firm reports, “The company is collaborating to set up a 3.60 megawatt (MW) DC solar project at Bellary District in the State of Karnataka (India) at an estimated cost of USD 0.75 million per MW of the solar capacity of the project. Sami-Sabinsa Group will subscribe to a minimum of 26% of the securities in this project and has signed a Security Subscription and Shareholders’ Agreement with O2 Energy, Singapore, and its Indian subsidiary towards the project.”
“Our investment in solar energy with a focus on adopting high-quality and environmentally friendly solutions will help us do our part in combatting climate change and reducing the carbon footprint,” said Dr. Muhammed Majeed, PhD, founder and chairman, Sami-Sabinsa Group, in the press release.
Anju Majeed, PhD, director, Sami-Sabinsa Group, added, “Furthermore, the initiative will create jobs for the local communities. This step will also help us improve energy efficiency at our manufacturing facilities while providing savings on energy costs.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
